Alpine Immune Sciences (ALPN, $64.55) was one of top quarterly gainers, jumping +24 to $64.55 per share. A.I.dvisor analyzed 916 stocks in the Biotechnology Industry over the last three months, and discovered that of them (5) charted an Uptrend while of them (4) trended down. A.I.dvisor found 417 similar cases when ALPN's price went up within three months. In out of those 417 cases, ALPN's price went down during the following month. Based on these historical data, A.I. thinks the odds of an Uptrend reversal for ALPN are